Fresenius Medical Care (FMS) Tops Q3 EPS Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/20/2024
- Nasdaq, S&P tumble as Netflix, chip stocks drag; AmEx boosts Dow
- Sony/Apollo bid for Paramount could be worth as much as $29 billion - Source
- Netflix Q1 earnings top estimates on blowout subscriber growth
- Nasdaq tumbles, Treasuries dip amid earnings, geopolitical crosscurrents
- Gold prices rally past $2,400 on reports of Israel strikes on Iran
- Jabil falls after placing CEO on paid leave amid internal investigation
- Tritium DCFC Limited (DCFC): Three Australian subsidiaries were determined to be insolvent or likely to become insolvent
- NVIDIA (NVDA) Shares Extend Drop To 10%, Erasing $212 Billion In Value - Bloomberg
- Tungray Technologies (TRSG) Prices 1.25M Share IPO at $4/sh
- Wells Fargo on Super Micro Computer (SMCI): 'No Positive Preannouncement
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
- After-hours movers: Alcoa rises; Equifax and Las Vegas Sands fall
- Midday movers: Travelers, JB Hunt fall; United Airlines rises
Universal American ACOs and Fresenius Medical Care Partner to Improve Health of End Stage Renal Disease Patients
October 26, 2016 8:30 AM EDTWALTHAM, Mass. & WHITE PLAINS, N.Y.--(BUSINESS WIRE)-- Collaborative Health Systems (CHS), a Universal American company (NYSE: UAM), and Fresenius Medical Care (NYSE: FMS), North Americas largest provider of kidney care services, announced an agreement today to provide integrated health care management for patients with renal disease who are enrolled in seven Medicare Shared Savings Program Accountable Care Organizations (MSSP ACOs) operated by CHS and physician partners. Under the agreement, the two companies will collaborate to improve outcomes and reduce the total cost of care for renal patients. With its wealth of... More
